Recombinant Human SLC25A13 Protein，His

SLC25A13, a member of the solute carrier family, encodes a mitochondrial carrier protein crucial for the transport of metabolites across the mitochondrial membrane, specifically in the context of the urea cycle and amino acid metabolism. Deficiencies in SLC25A13 have been linked to a rare genetic disorder known as citrin deficiency, which can lead to severe metabolic disturbances, including hyperammonemia and fatty liver disease. The investigation of SLC25A13 recombinant proteins has emerged as a critical area of research to elucidate the functional dynamics of this transporter, its interaction with various substrates, and the underlying mechanisms governing its activity. By expressing and purifying recombinant SLC25A13 in heterologous systems, researchers aim to perform in vitro studies that assess the protein's transport capabilities and structural properties. Such studies can provide insights into the pathophysiological implications of SLC25A13 mutations and may facilitate the development of targeted therapeutic strategies. Understanding how SLC25A13 functions not only contributes to the broader field of mitochondrial biology and metabolic disease but also holds potential for advancing personalized medicine approaches in treating disorders associated with dysfunctional mitochondrial transport.